Imaging technique accurately detects ccRCC

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from NIH to improve follow-up care for colorectal cancer screening in underserved populations.

October 04, 2024

Vol.50 No.37

Clinical Roundup

UCLA investigators develop collection of sarcoma patient-derived organoids for personalized cancer treatments

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient.

September 27, 2024

Vol.50 No.36

In Brief

John Ashton named associate director for shared resources at Wilmot Cancer Institute

John M. Ashton, associate professor in the department of biomedical genetics, has been promoted from assistant director to associate director of shared resources at the University of Rochester’s Wilmot Cancer Institute.

September 13, 2024

Vol.50 No.34

In Brief

USC Norris to open radiation oncology and imaging center in Newport Beach

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, will open a Newport Beach location offering the latest advancements in radiation therapy and diagnostic imaging.

September 13, 2024

Vol.50 No.34

Drugs & Targets

Expanded access program opens in the U.S. for TLX101-CDx, Telix’s investigational glioma imaging agent

Telix opened an expanded access program in the United States for TLX101-CDx (Pixclara, 18F-floretyrosine or 18F-FET) an investigational positron emission tomography agent for imaging progressive or recurrent glioma, following FDA agreement to proceed.

August 02, 2024

Vol.50 No.31

In Brief

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $4 million grant from NCI to help advance immune-based therapies to improve treatments and outcomes for people diagnosed with pancreatic ductal adenocarcinoma.

July 26, 2024

Vol.50 No.30

Imaging technique accurately detects ccRCC

YOU MAY BE INTERESTED IN

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

UCLA investigators develop collection of sarcoma patient-derived organoids for personalized cancer treatments

John Ashton named associate director for shared resources at Wilmot Cancer Institute

USC Norris to open radiation oncology and imaging center in Newport Beach

Expanded access program opens in the U.S. for TLX101-CDx, Telix’s investigational glioma imaging agent

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login